Serco acquires a number of Carillion healthcare contracts at near half price

By Catherine Sturman
Share
Following on from its financial collapse, Carillion has sought to sell a number of its healthcare contracts in order to counteract up to a £900mn debt...

Following on from its financial collapse, Carillion has sought to sell a number of its healthcare contracts in order to counteract up to a £900mn debt pile.

Public services giant Serco has now stated it will now acquire a large number of the company’s healthcare contracts for near on half what was previously agreed.

From £47.7mn to £29.7mn, the revised Business Purchase Agreement is a consequence of Carillion’s collapse into liquidation, where its contracts are no longer lucrative. With no working capital, the contracts will undoubtedly come with a number of caveats and put off other prospective buyers.

See also

Nonetheless, its future potential to further strengthen Serco’s healthcare business capabilities will remain unaffected through the acquisition.

Generating over £300 in revenue per annum, the contracts will enable the company to gain several new contracts covering a number of organisations and services, boosting its overall competitiveness in the market

Since Carillion’s collapse, close to a thousand jobs have been affected, The Independent has reported.

Employing over 50,000 people, Serco continues to operate internationally, where it places a global focus within five key sectors: Defence, Justice & Immigration, Transport, Health and Citizen Services. 

Share

Featured Articles

How Huawei's Digital Solutions are Transforming Healthcare

Offering network, cloud, and AI solutions, Huawei is able to help healthcare providers deliver better outcomes for patients

2024 Nestlé Nutrition Symposium Explored Food & Health

Nestlé manufactures 4.5m KitKats every day, but the food giant is also focused on advancing food nutrition, as explored at the 2024 International Symposium

Thirona’s AI Tech is Creating Individualised Patient Care

Eva van Rikxoort, CEO and Founder of Thirona, tells us how AI technology is advancing lung imaging and bringing more individualised treatment to patients

AstraZeneca’s Discovery Centre, Constructed by Mace Group

Technology & AI

NeoGenomics: Data in Oncology Testing & Diagnostics

AI & ML

Samsung’s New Health Software Development Kit Suite

Digital Healthcare